ArticleCurrent oncology (Toronto, Ont.)2021

Real-World Palbociclib Use in HR+/HER2- Advanced Breast Cancer in Canada: The IRIS Study.

Katie Mycock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.